Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas Lauder

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
European Heart Journal|December 8, 2022
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trialMichael Bhm, Stefan Anker, Felix Mahfoud, et al.
European Heart Journal|July 16, 2020
Randomized trials of invasive cardiovascular interventions that include a placebo control: a systematic review and meta-analysisLucas Lauder, Bruno R da Costa, Sebastian Ewen, et al.
Hypertension (Dallas, Tex. : 1979)|June 15, 2023
Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINEFelix Mahfoud, Giuseppe Mancia, Roland E Schmieder, et al.
Hypertension (Dallas, Tex. : 1979)|April 25, 2024
Artificial Intelligence-Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood PressurePedro Guimarães, Andreas Keller, Michael Böhm, et al.
Scientific Reports|April 26, 2026
Renal denervation attenuates cardiac fibrosis and improves left ventricular function in rats with myocardial infarctionMarkus Therre, Mathias Hohl, Parisa Aghagolzadeh, et al.
Hypertension (Dallas, Tex. : 1979)|March 4, 2026
Interplay of Age and Sex With Clinic and Ambulatory Blood Pressure and MortalityMichael Böhm, Alejandro de la Sierra, Igor Schwantke, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 11, 2018
Renal artery anatomy assessed by quantitative analysis of selective renal angiography in 1,000 patients with hypertensionLucas Lauder, Sebastian Ewen, Abraham Rami Tzafriri, et al.
European Journal of Preventive Cardiology|July 18, 2025
Long-term outcomes following radiofrequency renal denervation: meta-analysis of 18 reportsFelix Mahfoud, David E Kandzari, Markus P Schlaich, et al.
European Heart Journal|November 7, 2022
Hypertension management in patients with cardiovascular comorbiditiesLucas Lauder, Felix Mahfoud, Michel Azizi, et al.
Circulation. Cardiovascular Interventions|September 2, 2021
Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant HypertensionFelix Mahfoud, Horst Sievert, Stefan Bertog, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
European Heart Journal|December 8, 2022
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trialMichael Bhm, Stefan Anker, Felix Mahfoud, et al.
European Heart Journal|July 16, 2020
Randomized trials of invasive cardiovascular interventions that include a placebo control: a systematic review and meta-analysisLucas Lauder, Bruno R da Costa, Sebastian Ewen, et al.
Hypertension (Dallas, Tex. : 1979)|June 15, 2023
Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINEFelix Mahfoud, Giuseppe Mancia, Roland E Schmieder, et al.
Hypertension (Dallas, Tex. : 1979)|April 25, 2024
Artificial Intelligence-Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood PressurePedro Guimarães, Andreas Keller, Michael Böhm, et al.
Scientific Reports|April 26, 2026
Renal denervation attenuates cardiac fibrosis and improves left ventricular function in rats with myocardial infarctionMarkus Therre, Mathias Hohl, Parisa Aghagolzadeh, et al.
Hypertension (Dallas, Tex. : 1979)|March 4, 2026
Interplay of Age and Sex With Clinic and Ambulatory Blood Pressure and MortalityMichael Böhm, Alejandro de la Sierra, Igor Schwantke, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 11, 2018
Renal artery anatomy assessed by quantitative analysis of selective renal angiography in 1,000 patients with hypertensionLucas Lauder, Sebastian Ewen, Abraham Rami Tzafriri, et al.
European Journal of Preventive Cardiology|July 18, 2025
Long-term outcomes following radiofrequency renal denervation: meta-analysis of 18 reportsFelix Mahfoud, David E Kandzari, Markus P Schlaich, et al.
European Heart Journal|November 7, 2022
Hypertension management in patients with cardiovascular comorbiditiesLucas Lauder, Felix Mahfoud, Michel Azizi, et al.
Circulation. Cardiovascular Interventions|September 2, 2021
Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant HypertensionFelix Mahfoud, Horst Sievert, Stefan Bertog, et al.
Pageof 11